Segment Information (Tables)
|
9 Months Ended |
Sep. 30, 2019 |
Segment Reporting [Abstract] |
|
Schedule of reportable business segment information |
Reportable business segment information is as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
|
Nine Months Ended September 30, |
|
|
|
2019 |
|
2018 |
|
2019 |
|
2018 |
Net sales: |
|
|
|
|
|
|
|
Asia |
$ |
33,717 |
|
|
$ |
34,063 |
|
|
$ |
102,475 |
|
|
$ |
97,593 |
|
Europe |
14,640 |
|
|
13,076 |
|
|
45,312 |
|
|
41,601 |
|
North America |
34,161 |
|
|
35,578 |
|
|
105,304 |
|
|
109,201 |
|
Latin America and Other |
6,006 |
|
|
6,111 |
|
|
17,429 |
|
|
19,041 |
|
Total net sales |
88,524 |
|
|
88,828 |
|
|
270,520 |
|
|
267,436 |
|
|
|
|
|
|
|
|
|
Contribution margin (1): |
|
|
|
|
|
|
|
Asia |
16,236 |
|
|
16,250 |
|
|
48,638 |
|
|
45,891 |
|
Europe |
4,865 |
|
|
4,035 |
|
|
14,692 |
|
|
13,744 |
|
North America |
12,169 |
|
|
12,337 |
|
|
37,587 |
|
|
36,929 |
|
Latin America and Other |
2,608 |
|
|
2,534 |
|
|
7,348 |
|
|
7,355 |
|
Total contribution margin |
35,878 |
|
|
35,156 |
|
|
108,265 |
|
|
103,919 |
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses (2) |
31,177 |
|
|
31,643 |
|
|
96,048 |
|
|
97,339 |
|
Operating income |
4,701 |
|
|
3,513 |
|
|
12,217 |
|
|
6,580 |
|
|
|
|
|
|
|
|
|
Other loss, net |
(1,243) |
|
|
(353) |
|
|
(985) |
|
|
(1,420) |
|
Income before provision for income taxes |
$ |
3,458 |
|
|
$ |
3,160 |
|
|
$ |
11,232 |
|
|
$ |
5,160 |
|
_________________________________________
(1) Contribution margin consists of net sales less cost of sales and volume incentives expense.
(2) Service fees in China totaled $2.8 million and $7.3 million for the three and nine-month periods ended September 30, 2019, respectively, compared to $2.7 million and $6.7 million for the three and nine-month periods ended September 30, 2018. These service fees are included in selling, general and administrative expenses.
|
Schedule of consolidated net sales revenue by geographical locations |
From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three and nine-month periods ended September 30, 2019 and 2018, as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
|
Nine Months Ended September 30, |
|
|
|
2019 |
|
2018 |
|
2019 |
|
2018 |
Net sales: |
|
|
|
|
|
|
|
United States |
$ |
31,579 |
|
|
$ |
33,182 |
|
|
$ |
97,734 |
|
|
$ |
101,322 |
|
South Korea |
15,226 |
|
|
18,271 |
|
|
52,677 |
|
|
52,463 |
|
Other |
41,719 |
|
|
37,375 |
|
|
120,109 |
|
|
113,651 |
|
|
$ |
88,524 |
|
|
$ |
88,828 |
|
|
$ |
270,520 |
|
|
$ |
267,436 |
|
|
Schedule of revenue generated by each of the Company's product lines |
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
|
Nine Months Ended September 30, |
|
|
|
2019 |
|
2018 |
|
2019 |
|
2018 |
Asia |
|
|
|
|
|
|
|
General health |
$ |
9,450 |
|
|
$ |
8,290 |
|
|
$ |
28,287 |
|
|
$ |
23,046 |
|
Immune |
105 |
|
|
228 |
|
|
462 |
|
|
663 |
|
Cardiovascular |
9,997 |
|
|
11,927 |
|
|
33,390 |
|
|
35,326 |
|
Digestive |
6,309 |
|
|
6,192 |
|
|
18,417 |
|
|
17,886 |
|
Personal care |
3,472 |
|
|
2,640 |
|
|
9,559 |
|
|
7,908 |
|
Weight management |
4,384 |
|
|
4,786 |
|
|
12,360 |
|
|
12,764 |
|
|
33,717 |
|
|
34,063 |
|
|
102,475 |
|
|
97,593 |
|
Europe |
|
|
|
|
|
|
|
General health |
$ |
5,232 |
|
|
$ |
4,857 |
|
|
$ |
16,352 |
|
|
$ |
15,785 |
|
Immune |
1,176 |
|
|
827 |
|
|
3,539 |
|
|
2,603 |
|
Cardiovascular |
2,433 |
|
|
2,666 |
|
|
8,050 |
|
|
8,529 |
|
Digestive |
3,374 |
|
|
2,865 |
|
|
10,555 |
|
|
9,227 |
|
Personal care |
1,905 |
|
|
1,308 |
|
|
5,065 |
|
|
3,519 |
|
Weight management |
520 |
|
|
553 |
|
|
1,751 |
|
|
1,938 |
|
|
14,640 |
|
|
13,076 |
|
|
45,312 |
|
|
41,601 |
|
North America |
|
|
|
|
|
|
|
General health |
$ |
14,823 |
|
|
$ |
15,405 |
|
|
$ |
45,505 |
|
|
$ |
47,231 |
|
Immune |
3,731 |
|
|
3,721 |
|
|
11,289 |
|
|
12,026 |
|
Cardiovascular |
4,780 |
|
|
4,998 |
|
|
14,791 |
|
|
14,635 |
|
Digestive |
7,946 |
|
|
8,389 |
|
|
25,190 |
|
|
25,896 |
|
Personal care |
1,617 |
|
|
1,496 |
|
|
4,563 |
|
|
4,340 |
|
Weight management |
1,264 |
|
|
1,569 |
|
|
3,966 |
|
|
5,073 |
|
|
34,161 |
|
|
35,578 |
|
|
105,304 |
|
|
109,201 |
|
Latin America and Other |
|
|
|
|
|
|
|
General health |
$ |
1,929 |
|
|
$ |
1,755 |
|
|
$ |
5,324 |
|
|
$ |
5,633 |
|
Immune |
664 |
|
|
617 |
|
|
1,874 |
|
|
1,884 |
|
Cardiovascular |
378 |
|
|
365 |
|
|
1,078 |
|
|
1,131 |
|
Digestive |
2,499 |
|
|
2,805 |
|
|
7,680 |
|
|
8,688 |
|
Personal care |
267 |
|
|
300 |
|
|
784 |
|
|
913 |
|
Weight management |
269 |
|
|
269 |
|
|
689 |
|
|
792 |
|
|
6,006 |
|
|
6,111 |
|
|
17,429 |
|
|
19,041 |
|
|
$ |
88,524 |
|
|
$ |
88,828 |
|
|
$ |
270,520 |
|
|
$ |
267,436 |
|
|
Schedule of consolidated property, plant and equipment by geographical locations |
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2019 |
|
December 31, 2018 |
Property, plant and equipment: |
|
|
|
United States |
$ |
56,587 |
|
|
$ |
60,606 |
|
Other |
4,465 |
|
|
3,455 |
|
Total property, plant and equipment, net |
$ |
61,052 |
|
|
$ |
64,061 |
|
|
Schedule of assets per segment |
Total assets per segment is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2019 |
|
December 31, 2018 |
Assets: |
|
|
|
Asia |
$ |
70,673 |
|
|
$ |
59,983 |
|
Europe |
17,147 |
|
|
16,414 |
|
North America |
117,973 |
|
|
109,091 |
|
Latin America and Other |
8,954 |
|
|
7,528 |
|
Total assets |
$ |
214,747 |
|
|
$ |
193,016 |
|
|